Status:
UNKNOWN
Evolution of Cochleovestibular Schwannomas
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Schwannoma
Eligibility:
All Genders
18+ years
Brief Summary
Investigators want to know the natural history of the vestibular schwannomas: increasing, decreasing or stability, by monitoring more than 3 MRIs during a span of more than 2 years. They will obtain 3...
Eligibility Criteria
Inclusion
- Age over 18 years
- having a typical vestibular schwannoma diagnosis during the first MRI, having a minimum of 3 internal auditory canal MRIs on the same machine (Signa HDxt, General Electric, Strasbourg, France) ) at the Hôpitaux Universitaires de Strasbourg
- patients consenting to participate
Exclusion
- intra-labyrinthical extension
- treatment before the 3 MRIs
- no injection of gadolinium
- atypical diagnosis
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04417868
Start Date
January 1 2019
End Date
July 1 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Imagerie 1
Srtrasbourg, Strasbourg, France, 67091